Format
Sort by
Items per page

Send to

Choose Destination

Best matches for BK polyomavirus multiple sclerosis:

Search results

Items: 1 to 20 of 21

1.

Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo.

Maru S, Jin G, Desai D, Amin S, Shwetank, Lauver MD, Lukacher AE.

mSphere. 2017 Nov 15;2(6). pii: e00494-17. doi: 10.1128/mSphereDirect.00494-17. eCollection 2017 Nov-Dec.

2.

Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Rossi F, Prosperini L, De Rossi N, Capra R, Rivanera D, Li X, Cinque P, Passeri L, Pozzilli C, Viscidi R.

Viral Immunol. 2017 Oct;30(8):622-626. doi: 10.1089/vim.2017.0039. Epub 2017 Aug 24.

PMID:
28836899
3.

Progressive Multifocal Leukoencephalopathy: Endemic Viruses and Lethal Brain Disease.

Haley SA, Atwood WJ.

Annu Rev Virol. 2017 Sep 29;4(1):349-367. doi: 10.1146/annurev-virology-101416-041439. Epub 2017 Jun 21. Review.

PMID:
28637388
4.

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.

Bilger A, Plowshay J, Ma S, Nawandar D, Barlow EA, Romero-Masters JC, Bristol JA, Li Z, Tsai MH, Delecluse HJ, Kenney SC.

Oncotarget. 2017 Jul 4;8(27):44266-44280. doi: 10.18632/oncotarget.17863.

5.

Polyomaviruses.

Cook L.

Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.DMIH2-0010-2015. Review.

PMID:
27726799
6.

Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: Profile and frequency of urinary shedding.

Nali LH, Fink MC, do Olival GS, Moraes L, Callegaro D, Tilbery CP, Vidal JE, Sumita LM, de Oliveira AC, Romano CM.

J Med Virol. 2017 Mar;89(3):528-534. doi: 10.1002/jmv.24646. Epub 2016 Aug 9.

PMID:
27464945
7.

Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Jelcic I, Combaluzier B, Jelcic I, Faigle W, Senn L, Reinhart BJ, Ströh L, Nitsch RM, Stehle T, Sospedra M, Grimm J, Martin R.

Sci Transl Med. 2015 Sep 23;7(306):306ra150. doi: 10.1126/scitranslmed.aac8691. Epub 2015 Sep 23.

8.

Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.

Kardas P, Leboeuf C, Hirsch HH.

J Clin Virol. 2015 Oct;71:28-33. doi: 10.1016/j.jcv.2015.07.305. Epub 2015 Jul 29.

PMID:
26370311
9.

JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.

Delbue S, Elia F, Carloni C, Pecchenini V, Franciotta D, Gastaldi M, Colombo E, Signorini L, Carluccio S, Bellizzi A, Bergamaschi R, Ferrante P.

J Neurovirol. 2015 Dec;21(6):645-52. doi: 10.1007/s13365-014-0268-0. Epub 2014 Jul 23.

PMID:
25052191
10.

An assay to quantify species-specific anti-JC virus antibody levels in MS patients.

Warnke C, Pawlita M, Dehmel T, Posevitz-Fejfar A, Hartung HP, Wiendl H, Kieseier BC, Adams O.

Mult Scler. 2013 Aug;19(9):1137-44. doi: 10.1177/1352458513475489. Epub 2013 Feb 6.

PMID:
23388163
11.

Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis.

Ribeiro T, Fleury MJ, Granieri E, Castellazzi M, Martini F, Mazzoni E, Coursaget P, Tognon M.

Neurol Sci. 2010 Aug;31(4):517-21. doi: 10.1007/s10072-010-0353-y. Epub 2010 Jun 15.

PMID:
20552238
12.

JCV detection in multiple sclerosis patients treated with natalizumab.

Sadiq SA, Puccio LM, Brydon EW.

J Neurol. 2010 Jun;257(6):954-8. doi: 10.1007/s00415-009-5444-4. Epub 2010 Jan 7.

PMID:
20052484
13.

Asymptomatic reactivation of JC virus in patients treated with natalizumab.

Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ.

N Engl J Med. 2009 Sep 10;361(11):1067-74. doi: 10.1056/NEJMoa0904267. Erratum in: N Engl J Med. 2011 May 12;364(19):1882.

14.

Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy.

Lonergan RM, Carr MJ, De Gascun CF, Costelloe LF, Waters A, Coughlan S, Duggan M, Doyle K, Jordan S, Hutchinson MW, Hall WW, Tubridy NJ.

J Neurovirol. 2009 Sep;15(5-6):351-9. doi: 10.3109/13550280903131923.

PMID:
19670070
15.

The role of polyomaviruses in human disease.

Jiang M, Abend JR, Johnson SF, Imperiale MJ.

Virology. 2009 Feb 20;384(2):266-73. doi: 10.1016/j.virol.2008.09.027. Epub 2008 Nov 7. Review.

16.

Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis.

Pietropaolo V, Fioriti D, Mischitelli M, Anzivino E, Santini M, Millefiorini E, Di Rezze S, Degener AM.

New Microbiol. 2005 Jul;28(3):199-203.

PMID:
16240691
17.
18.

Immunocytochemical search for JC papovavirus large T-antigen in multiple sclerosis brain tissue.

Stoner GL, Ryschkewitsch CF, Walker DL, Soffer D, Webster HD.

Acta Neuropathol. 1986;70(3-4):345-7.

PMID:
3532688
19.

Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.

Chesters PM, Heritage J, McCance DJ.

J Infect Dis. 1983 Apr;147(4):676-84.

PMID:
6302172
20.

In vitro-labeled DNA for detecting viral genomes in multiple sclerosis: I. Papovaviruses.

Meinke W, Smith RA, Lancaster WD, Goldstein DA, Tourtellotte WW, Spizizen J.

Neurology. 1977 Aug;27(8):736-40.

PMID:
196234

Supplemental Content

Loading ...
Support Center